OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced a global licensing agreement with Eli Lilly and Company ("Lilly"). This collaboration focuses on ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Edwards Lifesciences (EW – Research Report), Arvinas Holding ...

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, today announced an expansion to the scope and breadth of its strategic collaboration with Eli Lilly ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic ...

CAMBRIDGE, Mass., January 29, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA ...

Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory filings ...

Astronomers trace the striking pattern to an encounter between a big galaxy and a much smaller one some 50 million years ago.

When Kid Rock tells a crowd to clap he expects them to clap. And, if they don’t clap, well at least during a show Saturday night in Nashville, he is not going to stick around. And he was not ...

This week's earnings releases include consumer companies. A number of IPOs are set to begin trading and Jan. CPI data will be released on Wednesday. See more.

The 2 nd Annual mRNA-Based Therapeutics Summit Europe is returning in-person to Berlin this January 24-26. Expect exclusive data from the movers and shakers in mRNA vaccine and therapy ...

Here is your 2025 hard rock + metal album release calendar and all of this week's newest albums! Each week is loaded with new rock and metal releases and keeping track of it all can be pretty ...